Hcw Biologics Inc (HCWB) Stock Price, Quote & News

Company Profile

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is i...

Industry: Biotechnology

Sector: Healthcare

Phone: 954 842 2024

Fax: 954 842 2037

Website: www.hcwbiologics.com

Address:

2929 North Commerce Parkway, Miramar, United States

RonTactical61 Jun. 16 at 2:54 PM

$HCWB the worst! Absolute trash. CEO should be fired.

0 · Reply

trader87 Jun. 12 at 4:08 PM

$HCWB swing idea again,and how the former one ended up🫡

1 · Reply

kdnapedIPOmidweek Jun. 11 at 10:22 PM

@Laurapicksright I ment $HCWB sorry

0 · Reply

sam92 Jun. 10 at 2:26 PM

$HCWB LSEG Stocks Plus Report Latest Report 06/08/2025 LSEG maintains a current price target of $35 for HCWB

0 · Reply

YasirTrades Jun. 10 at 5:42 AM

GLMD more news! + big short interest , has Fast Track designation from the FDA, multiple Phase 3 results, and is now expanding into oncology + GLP 1 combos. Ran to $24 and can do it again. Meanwhile, shorts pay over 100% to borrow. 📉 + 🔥 catalysts = prime squeeze setup. $LUCY $NIVF $INM $HCWB !!!

0 · Reply

Chi2ggzz Jun. 6 at 10:23 PM

$HCWB This has been taking a beating, meanwhile smart money keeps soaking. This is going to gap so hard one day lol I will be making back my loss on this plus a fuck ton more. Back in this Monday, I’ll take 6 :)

0 · Reply

ReggieSanchez Jun. 5 at 2:54 PM

$HCWB

0 · Reply

simplifocused Jun. 5 at 8:48 AM

$HCWB just sharing this news about HCWB: $LIMN $CTNT $VRNT NFA

0 · Reply

simplifocused Jun. 4 at 10:43 PM

$HCWB HCW Biologics And WY Biotech Finalize Binding Agreement Following Due Diligence On Technology Transfer For Immunotherapy Molecule HCW11-006, With HCWB Receiving $7M Upfront License Fee And Eligibility For Milestone Payments And Royalties While Retaining Option To Recapture North And Central American Rights Post-Phase 1 Trial Benzinga · 06/04/2025 13:40 NFA

0 · Reply

Substanceabuse99 Jun. 4 at 6:58 PM

$ALZN $HCWB $HOOD $MULN $TPST

0 · Reply

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

May 15, 2025, 6:14 PM EDT - 4 weeks ago

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

May 13, 2025, 8:01 PM EDT - 4 weeks ago

HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

May 13, 2025, 8:30 AM EDT - 4 weeks ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Apr 1, 2025, 4:35 PM EDT - 2 months ago

HCW Biologics Announces 1-for-40 Reverse Stock Split

Mar 28, 2025, 3:30 PM EDT - 2 months ago

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

Mar 6, 2025, 6:55 AM EST - 3 months ago

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

Feb 3, 2025, 7:15 AM EST - 4 months ago

HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

Jan 15, 2025, 7:00 AM EST - 5 months ago

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

Dec 23, 2024, 8:10 AM EST - 6 months ago

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Nov 18, 2024, 9:27 PM EST - 7 months ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

Nov 18, 2024, 10:15 AM EST - 7 months ago

Why Is Penny Stock HCW Biologics Surging On Monday?

Nov 18, 2024, 7:00 AM EST - 7 months ago

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

Nov 14, 2024, 4:40 PM EST - 7 months ago

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

Aug 23, 2024, 4:30 PM EDT - 10 months ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

Aug 14, 2024, 4:35 PM EDT - 10 months ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

May 15, 2024, 4:39 PM EDT - 1 year ago

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

Apr 1, 2024, 4:10 PM EDT - 1 year ago

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Nov 14, 2023, 7:00 AM EST - 1 year ago

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

Nov 8, 2023, 7:30 AM EST - 1 year ago

Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Nov 1, 2023, 7:30 AM EDT - 1 year ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

Sep 6, 2023, 7:30 AM EDT - 1 year ago

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

Aug 11, 2023, 7:00 AM EDT - 2 years ago

HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Jun 14, 2023, 7:30 AM EDT - 2 years ago

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

May 9, 2023, 7:15 AM EDT - 2 years ago

HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights

Apr 27, 2023, 7:40 AM EDT - 2 years ago

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

Apr 13, 2023, 7:15 AM EDT - 2 years ago

HCW Biologics Poster Presentation at AACR Annual Meeting 2023

Apr 3, 2023, 8:13 AM EDT - 2 years ago

A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases

Mar 28, 2023, 4:25 PM EDT - 2 years ago

HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Dec 8, 2022, 7:55 AM EST - 2 years ago

HCW Biologics Enters CRADA with National Cancer Institute

Dec 7, 2022, 7:30 AM EST - 2 years ago

HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform

Nov 8, 2022, 7:00 AM EST - 2 years ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting

Nov 7, 2022, 4:45 PM EST - 2 years ago

HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights

Aug 31, 2022, 9:22 AM EDT - 3 years ago

HCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

SMSI

Aug 29, 2022, 8:58 AM EDT - 3 years ago

CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying

CASI HSDT

Aug 12, 2022, 7:00 AM EDT - 3 years ago

HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights

Aug 3, 2022, 7:15 AM EDT - 3 years ago

U.S. Patent Issued to HCW Biologics for Foundational Platform Technology

May 23, 2022, 7:30 AM EDT - 3 years ago

HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022

May 13, 2022, 7:15 AM EDT - 3 years ago

HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights

May 5, 2022, 7:30 AM EDT - 3 years ago

HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists

Apr 19, 2022, 7:33 AM EDT - 3 years ago

HCW Biologics' CEO Hing C. Wong, Ph.D.

Mar 28, 2022, 7:00 AM EDT - 3 years ago

HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021

Mar 24, 2022, 8:00 AM EDT - 3 years ago

HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest

Jan 24, 2022, 9:22 AM EST - 3 years ago

Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers

Jan 24, 2022, 7:00 AM EST - 3 years ago

Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics' Novel Bifunctional Fusion Protein

Jan 20, 2022, 9:24 AM EST - 3 years ago

HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo

Jan 20, 2022, 8:00 AM EST - 3 years ago

HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens

Jan 19, 2022, 8:00 AM EST - 3 years ago

HCW Biologics' Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institute's Annual PepTalk Conference 2022

Jan 6, 2022, 7:33 AM EST - 3 years ago

HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022

Dec 13, 2021, 7:31 AM EST - 3 years ago

HCW Biologics' Founder and CEO Dr. Hing C. Wong Named Weaver H.

RonTactical61 Jun. 16 at 2:54 PM

$HCWB the worst! Absolute trash. CEO should be fired.

0 · Reply

trader87 Jun. 12 at 4:08 PM

$HCWB swing idea again,and how the former one ended up🫡

1 · Reply

kdnapedIPOmidweek Jun. 11 at 10:22 PM

@Laurapicksright I ment $HCWB sorry

0 · Reply

sam92 Jun. 10 at 2:26 PM

$HCWB LSEG Stocks Plus Report Latest Report 06/08/2025 LSEG maintains a current price target of $35 for HCWB

0 · Reply

YasirTrades Jun. 10 at 5:42 AM

0 · Reply

Chi2ggzz Jun. 6 at 10:23 PM

0 · Reply

ReggieSanchez Jun. 5 at 2:54 PM

$HCWB

0 · Reply

simplifocused Jun. 5 at 8:48 AM

$HCWB just sharing this news about HCWB: $LIMN $CTNT $VRNT NFA

0 · Reply

simplifocused Jun. 4 at 10:43 PM

0 · Reply

Substanceabuse99 Jun. 4 at 6:58 PM

$ALZN $HCWB $HOOD $MULN $TPST

0 · Reply

DexterTrader Jun. 4 at 1:09 PM

$HCWB news?

1 · Reply

mebanks Jun. 4 at 12:55 PM

$HCWB ; Low float (Finviz, Shs Float 1.16M) with confirmed commitment and 7M cash (Note that some warrants maybe pending at $7.45) - "In addition, WY Biotech confirmed its commitment to proceed with the development and commercialization of the licensed molecule, HCW11-006, for in vivo therapeutic applications. The Agreement is now fully binding and HCW Biologics has earned the $7.0 million upfront license fee under the terms of the Agreement, as amended"

0 · Reply